Skip to main content
Janet McGill, MD, Endocrinology, Saint Louis, MO

JanetBMcGillMDMA, FACE, FACP

Endocrinology Saint Louis, MO

Diabetes, Lipid Metabolism, Thyroid

Professor of Medicine, Washington University St Louis

Dr. McGill is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. McGill's full profile

Already have an account?

  • Office

    4921 Parkview Pl
    # Dv
    Saint Louis, MO 63110
    Phone+1 314-362-3500
    Fax+1 314-230-1119

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Endocrinology, Diabetes, and Metabolism, 1985 - 1987
  • Beaumont Hospital, Royal Oak
    Beaumont Hospital, Royal OakFellowship, Endocrinology, Diabetes, and Metabolism, 1984 - 1985
  • Corewell Health East Beaumont (Royal Oak)
    Corewell Health East Beaumont (Royal Oak)Residency, Internal Medicine, 1980 - 1984
  • Michigan State University College of Human Medicine
    Michigan State University College of Human MedicineClass of 1979

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 1985 - 2025
  • MI State Medical License
    MI State Medical License 1981 - 2003
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Outstanding Physician Clinician in Diabetes American Diabetes Association, 2022
  • America's Top Doctors Castle Connolly, 2007-2022
  • Excellence in Teaching Washington University, 2020
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults with Type 1 Diabetes  
    Anuj Bhargava, Robin Goland, Irl B Hirsch, Yogish C Kudva, Janet B Mcgill, Louis Philipson, Francesco Vendrame, Ruth S Weinstock, JAMA
  • Late-Onset T1DM and Older Age Predict Risk of Additional Autoimmune Disease  
    Kavita Juneja, Janet B McGill, Jing W Hughes, Garry S Tobin, C Rachel Kilpatrick, Diabetes Care

Lectures

  • New Strategies for Obesity Management: Risk Stratification & Long-term Weight Control 
    American Association of Clinical Endocrinologists (AACE), Novi, Michigan - 10/11/2013
  • New Strategies for Obesity Management: Risk Stratification & Long-term Weight Control 
    American Association of Clinical Endocrinologists (AACE), Novi, Michigan - 10/11/2013
  • Hot Topics in Internal Medicine - CME Getaways Las Vegas 
    CME Getaways, Las Vegas, Nevada - 9/28/2012

Authored Content

  • Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults with Type 1 DiabetesJune 2020

Press Mentions

  • Finerenone plus SGLT2 Inhibition May Yield Additive CV, Kidney Benefits: FIGARO-DKD
    Finerenone plus SGLT2 Inhibition May Yield Additive CV, Kidney Benefits: FIGARO-DKDOctober 5th, 2021
  • Clinical Highlights: 15th Annual CMHC Live Online
    Clinical Highlights: 15th Annual CMHC Live OnlineOctober 29th, 2020
  • YOUR HEALTH: Can Type 2 Medicines Help Type 1 Diabetics?
    YOUR HEALTH: Can Type 2 Medicines Help Type 1 Diabetics?September 27th, 2019
  • Join now to see all

Grant Support

  • Diabetes Research And Training CenterNational Institute Of Diabetes And Digestive And Kidney Diseases2007
  • The Dream StudyNational Center For Research Resources2004–2007
  • Bypass Angioplasty Revascularization Investigation 2 Diabetes (Bari 2d)National Center For Research Resources2005
  • Early Diabetes Intervention Program (EDIP)National Center For Research Resources1999–2005
  • Early Diabetes Intervention Program. (EDIP)National Center For Research Resources2004
  • Correlation Of 15ag To Established Glycemia Markers In DiabetesNational Center For Research Resources2004
  • Bypass Angioplasty Revascularization Investigation 2 Diabetes (Bari 2d).National Center For Research Resources2004
  • Plant Sterols In Cholesterol AbsorptionNational Center For Research Resources2000–2002
  • Nabumetone, Celcoxib &Ibuprofen On Blood Pressure Control In HypertensionNational Center For Research Resources2000–2002
  • Inhaled Vs. Subcutaneous Human Insulin Therapy In Type 2 DiabetesNational Center For Research Resources2000–2002
  • Inhaled Human Insulin Therapy In Type 2 DiabetesNational Center For Research Resources2000–2002
  • Gi262570 Sodium Tablets W/ Metformin For 26 WKS In NIDDMNational Center For Research Resources2000–2002
  • Gi262570 Sodium Tablets Monotherapy For 26wks In NIDDMNational Center For Research Resources2000–2002
  • External Continuous Subcutaneous Insulin Aspart Infusion In NIDDMNational Center For Research Resources2000–2002
  • External Continuous Infusion Of Insulin Aspart, Lispro &Buffered Regular In IDDMNational Center For Research Resources2000–2002
  • Evaluation Of Multi Dose Regimen L-753,037 In African Americans With HypertensionNational Center For Research Resources2000–2002
  • Evaluate 3 Fixed Doses Of SDZ Djn 608 In NIDDMNational Center For Research Resources2000–2002
  • Effect Of A-100 On Glycemic Control In Overweight NIDDM Treated With MetforminNational Center For Research Resources2000–2002
  • Diabetes Center--Clinical Research Facility, Research, And TrainingNational Center For Research Resources2000–2002
  • Comparison Of Tcpi Td-Glucose With Finger Stick MethodsNational Center For Research Resources2000–2002
  • SDZ Djn 608 Monotherapy Compared To Glibenclamide Monotherapy B304 ENational Center For Research Resources1999–2002
  • Repaglinide And Troglitazone In Treatment Of Type II Diabetes MellitusNational Center For Research Resources1999–2002
  • Oral Gi262570x Monotherapy 12weeks Duration Subjects With Type2 DiabetesNational Center For Research Resources1999–2002
  • Metformin And Glyburide Combination Products In Diabetes PatientsNational Center For Research Resources1999–2002
  • Brl49653c Combination With Glyburide To Patients With DiabetesNational Center For Research Resources1999–2002
  • Brl49653 Combination With Insulin To Patients With Noninsulin Dependent DiabetesNational Center For Research Resources1999–2002
  • Antiproteinuric Effects Of Omapatrilat And Amlodipine In Type II DiabetesNational Center For Research Resources1999–2002
  • 52 Week, Orlistat Treatment In Obese Patients With Type 2 Diabetes MellitusNational Center For Research Resources1999–2002
  • Oral Zopolrestat In Subjects With Peripheral Symmetrical Diabetic PolyneuropathyNational Center For Research Resources1998–2002
  • 26 Weeks Of BRL 49653c Given 2X Day To Patients W/ NIDDM &Inadequate ControlNational Center For Research Resources1998–2002
  • Renal Protective Effects Of Losartan In Patients With NIDDM And NephropathyNational Center For Research Resources1997–2002
  • OPEN Label Long Term Tolerability Of Pioglitazone AD 48333 In NIDDM PatientsNational Center For Research Resources1997–2002
  • Oral Zololrestat In Normotensive, Type I Diabetics With Incipient NephropathyNational Center For Research Resources1996–2002
  • Diabetes Registry--Research And Education FacilityNational Center For Research Resources1996–2002
  • Oral Gi26257ox In Patients W Type II Diabetes MellitusNational Center For Research Resources1999
  • Randomized Study To Determine Effects Of Subcutaneous Recombinant LeptinNational Center For Research Resources1998–1999
  • PET Detection Of The Diabetic HeartNational Center For Research Resources1998–1999
  • Intra And Intersubject Variability In Absorption Of Subcutaneous InsulinNational Center For Research Resources1998–1999
  • Human Insulin Analogue X14 &Regular Human Insulin As Meal Related InsulinNational Center For Research Resources1998–1999
  • Evaluation Of Dose Ranges Of SC 6610 In Treatment Of HypertensionNational Center For Research Resources1998–1999
  • Evaluate Safety, Efficacy And Tolerability Of 3 Fixed Doses Of SDZ Djn 608National Center For Research Resources1998–1999
  • Effects Of Subcutaneous Admin Of Insulin &Rhigf 1 In Subjects With IDDMNational Center For Research Resources1998–1999
  • BRL 49653c Admin 1X Day To PTS W/ NIDDM Inadequately Controlled On GlyburideNational Center For Research Resources1998–1999
  • 28 Week OPEN Clinical Trial Comparing HOE 901 Insulin With NPH Human InsulinNational Center For Research Resources1998–1999
  • 16 Week Multicenter Clinical Trial Comparing H0e901 W/ NPH Human InsulinNational Center For Research Resources1998–1999
  • Venlafaxine ER Capsules For Chronic Pain Associated With Diabetic NeuropathyNational Center For Research Resources1997–1999
  • Tolerability Of Pramlintide In Patients With Type I DiabetesNational Center For Research Resources1997–1999
  • Telmisartan As Monotherapy Or In Combination With Other Antihypertensive DrugsNational Center For Research Resources1997–1999
  • Sucralose Versus Placebo On Glucose Homeostasis In NIDDM SubjectsNational Center For Research Resources1997–1999
  • Oral Ana756 In Treatment Of Patients With Essential HypertensionNational Center For Research Resources1997–1999
  • Pimagedine In Patients With Type II Diabetes Mellitus And Diabetic NephropathyNational Center For Research Resources1996–1999
  • Efect Of Ac137 On Plasma Glucose Profiles In Patients With Type II DiabetesNational Center For Research Resources1996–1999
  • Aminoguanidine In Diabetic Patients With Overt Diabetic NephropathyNational Center For Research Resources1996–1999
  • Two Formulations Of HOE 901 Insulin In Comparison To NPH Insulin In NIDDMNational Center For Research Resources1997
  • Telmisartan And Hctz In Patients With Mild To Moderate Essential HypertensionNational Center For Research Resources1997
  • Oral Zopolrestat In Subjects With Peripheral Symmetical Diabetic PolyneuropathyNational Center For Research Resources1997
  • Orlistat In The Treatment Of Obese Subjects With NIDDMNational Center For Research Resources1996–1997
  • Miglitol As Compared To A Fixed Dose Of Sulfonylurea In The Treatment Of NIDDMNational Center For Research Resources1996–1997
  • Metformin Hydrochloride In Patients With Noninsulin Dependent Diabetes MellitusNational Center For Research Resources1996–1997
  • Ci-991 In NIDDM To Assess Potential Effects On Cardiac Mass And FunctionNational Center For Research Resources1996–1997
  • Angiotensin Converting Enzyme Inhibition In Diabetic NephropathyNational Center For Research Resources1996–1997
  • U-98079a (DAV6215CL) Capsules In The Treatment Of Mixed Anxiety And DepressionNational Center For Research Resources1996
  • Triproamylin On Glucose Profile And Pharmacokinetics In Juvenile Onset DiabetesNational Center For Research Resources1996
  • Oral Dose Levels Of Rs-15385-197 In Men With Erectile DisorderNational Center For Research Resources1996
  • Occlusions Of Insulin Delivery In Continuous Subcutaneous Insulin Infusion (HumanNational Center For Research Resources1990
  • Multicenter Clinical Trial Converting Enzyme Inhibition In Diabetic NephropathyNational Center For Research Resources1990
  • Energy Metabolism During AnesthesiaNational Center For Research Resources1990
  • Effect Of Captopril On Microalbuminia/Insulin Dependent Diabetes MellitusNational Center For Research Resources1990

Committees

  • member, AACE/ACE Comprehensive Type 2 Diabetes Management Algorithm 2033
  • member, AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN 2015
  • member, AACE/ACE COMPREHENSIVE DIABETES MANAGEMENT ALGORITHM 2015
  • member, 2011 AACE Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan
  • member, CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM 2016 EXECUTIVE SUMMARY

Professional Memberships